Top Line: Nicox SA an international ophthalmology company, announced the launch of its redesigned corporate and investor website,
Close Up: The new corporate website features:
• New visual image for Nicox
• Introductory video on the company
• Mechanism-of-action video on NCX 470, Nicox’s lead product candidate in glaucoma
• New layout and easier access to key information on the company
Vital Stats: Nicox is an international ophthalmology company with two product candidates in clinical development—one in Phase 3 in glaucoma and another one in Phase 2b in blepharitis—and recurrent licensing revenue from partners on two commercialized products.